Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length

Glia. 2017 Feb;65(2):309-321. doi: 10.1002/glia.23093. Epub 2016 Oct 31.

Abstract

Adjusting the thickness and internodal length of the myelin sheath is a mechanism for tuning the conduction velocity of axons to match computational needs. Interactions between oligodendrocyte precursor cells (OPCs) and developing axons regulate the formation of myelin around axons. We now show, using organotypic cerebral cortex slices from mice expressing eGFP in Sox10-positive oligodendrocytes, that endogenously released GABA, acting on GABAA receptors, greatly reduces the number of oligodendrocyte lineage cells. The decrease in oligodendrocyte number correlates with a reduction in the amount of myelination but also an increase in internode length, a parameter previously thought to be set by the axon diameter or to be a property intrinsic to oligodendrocytes. Importantly, while TTX block of neuronal activity had no effect on oligodendrocyte lineage cell number when applied alone, it was able to completely abolish the effect of blocking GABAA receptors, suggesting that control of myelination by endogenous GABA may require a permissive factor to be released from axons. In contrast, block of AMPA/KA receptors had no effect on oligodendrocyte lineage cell number or myelination. These results imply that, during development, GABA can act as a local environmental cue to control myelination and thus influence the conduction velocity of action potentials within the CNS. GLIA 2017;65:309-321.

Keywords: GABA; internode; myelination; oligodendrocyte; precursor; proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axons / drug effects
  • Axons / physiology*
  • Axons / ultrastructure
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Cell Proliferation / drug effects
  • Cell Proliferation / genetics
  • Cerebral Cortex / cytology*
  • Cerebral Cortex / physiology
  • Excitatory Amino Acid Antagonists / pharmacology
  • GABA Agents / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Mice
  • Mice, Transgenic
  • Myelin Sheath / metabolism*
  • Myelin Sheath / ultrastructure
  • Neurons / cytology
  • Neurons / drug effects
  • Oligodendroglia / drug effects
  • Oligodendroglia / physiology*
  • Oligodendroglia / ultrastructure
  • Organ Culture Techniques
  • Organogenesis / drug effects
  • Organogenesis / physiology*
  • Quinoxalines / pharmacology
  • Receptors, GABA / genetics
  • Receptors, GABA / metabolism
  • SOXE Transcription Factors / genetics
  • SOXE Transcription Factors / metabolism
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / genetics
  • Tetrodotoxin / pharmacology
  • gamma-Aminobutyric Acid / metabolism*
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • Excitatory Amino Acid Antagonists
  • GABA Agents
  • Quinoxalines
  • Receptors, GABA
  • SOXE Transcription Factors
  • Sox10 protein, mouse
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • Tetrodotoxin
  • gamma-Aminobutyric Acid